Wilson Sonsini Goodrich & Rosati has invested in genomic sequencing amplification startup BioSkryb as part of an $11.5m round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Jasper Therapeutics, based in part on Stanford research, has raised a $15m series A extension on the back of early clinical results from its blood transplant conditioning program.

Mayo Clinic has bet on chronic disease drug developer Novome Biotechnologies, which is initially targeting a disorder known as hyperoxaluria.

Foxconn, Chow Tai Fook, Hogy Medical and Varian Medical have all invested in a round that took the surgical robot developer's total financing to $160m.

The DNA sequencing technology developer, which counts Nan Fung and Lam Research as investors, has added $60m to take its funding to $145m in the last 18 months.

The healthcare scheduling software provider boosted its total funding to almost $120m in a round backed by Providence Ventures and Salesforce Ventures.

Roche Venture Fund led a $14.1m extension for Jasper Therapeutics, developer of a conditioning agent for haematopoietic cell transplants, boosting the round to more than $49m.

McKesson-backed healthcare macrodata platform developer Komodo Health snagged the cash in a series C round led by Andreessen Horowitz.

Stanford-StartX Fund-backed Inflammatix received series C funding led by Grey Sky ahead of the European release of its acute infection diagnostics platform.